Feasibility and acceptability of a dignity therapy/life plan intervention for patients with advanced cancer

Ann Marie Dose, Joleen M. Hubbard, Aaron S. Mansfield, Pamela J. McCabe, Catherine A. Krecke, Jeff A. Sloan

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Purpose/Objectives: To determine the feasibility and acceptability of a dignity therapy/life plan intervention in the outpatient oncology setting. Research Approach: Pilot descriptive study. Setting: Outpatient clinic in a tertiary oncology center. Participants: 18 patients within 12 months after diagnosis undergoing treatment for advanced pancreatic cancer or non-small cell lung cancer. Methodologic Approach: Patients received dignity therapy, consisting of a focused life review/values clarification interview session and two subsequent sessions to produce a generativity document, which they can use later as they wish. Participants also wrote a life plan, in which they listed future hopes and dreams. Intervention feasibility and acceptability for patients and oncology clinician satisfaction were assessed. Findings: Among the 18 patients completing the intervention, almost all felt it was worthwhile, would do it again, had their expectations met or exceeded, would recommend it to others, and said the timing was just right. Interpretation: This psychosocial intervention was found to be feasible and acceptable to patients with cancer undergoing active treatment. Implications for Nursing: Nurses may be in an ideal position to offer a dignity therapy/life plan intervention to patients with advanced cancer during treatment.

Original languageEnglish (US)
Pages (from-to)E194-E202
JournalOncology nursing forum
Issue number5
StatePublished - Sep 2017


  • Carcinoma
  • Feasibility studies
  • Human dignity
  • Non-small cell lung
  • Pancreatic cancer
  • Quality of life

ASJC Scopus subject areas

  • Oncology(nursing)


Dive into the research topics of 'Feasibility and acceptability of a dignity therapy/life plan intervention for patients with advanced cancer'. Together they form a unique fingerprint.

Cite this